Home » Newsletters » BioWorld Asia

BioWorld Asia

Dec. 27, 2000

View Archived Issues

EntoMed Raises EUR20M For Programs In Resistant Infections

Oxagen Raises #30M To Boost Its Efforts Linking Genes To Disease

PanTherix Secures Funding To Move Compounds Into Phase II

Merged Company Cardion Raises EUR42.3M In Third-Round Funding

UK Parliament Relaxes Rules On Harvesting Of Stem Cells

Crucell Grants Eurogene License To Adenoviral Cell Line Platform

EU Agreement Nears On GMO Authorization Rules

Direvo Completes Seed Funding For Directed-Evolution Program

European Commission Welcomes Parliament's Inquiry On Genetics

EirX Completes Second-Round Funding For Apoptosis Focus

Other News To Note

Neuro 3D Raises EUR7.6M In Seed Funding For CNS Work

Differences Over Biotechnology Not Insurmountable, Says Report

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...